{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ02206",
      "entity_text" : "factor FIX",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1001" ],
      "CellType" : [ "cl:CL:0000084" ]
    }
  },
  "verbose_text" : "Transgene product expression by AAV vectors with a dsDNA genome is more efficient and in a recent trial a dsAAV8 vector achieved near therapeutic levels of factor FIX in hemophilia patients without evidence of T cell activation if given at a dose of 2 x 10 10 vg/kg.",
  "reading_complete" : "2020-08-08T09:35:54Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T09:35:33Z",
  "trigger" : "levels",
  "evidence" : [ "levels of factor FIX" ],
  "pmc_id" : "3136725",
  "score" : 0
}